J Quinn

7.5k total citations
97 papers, 6.1k citations indexed

About

J Quinn is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, J Quinn has authored 97 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 46 papers in Oncology and 19 papers in Immunology. Recurrent topics in J Quinn's work include Bone Metabolism and Diseases (54 papers), Bone health and treatments (36 papers) and Cell Adhesion Molecules Research (14 papers). J Quinn is often cited by papers focused on Bone Metabolism and Diseases (54 papers), Bone health and treatments (36 papers) and Cell Adhesion Molecules Research (14 papers). J Quinn collaborates with scholars based in Australia, United Kingdom and United States. J Quinn's co-authors include Matthew T. Gillespie, N. A. Athanasou, J O McGee, T. John Martin, Natalie A. Sims, T. John Martin, N A Athanasou, Vicky Kartsogiannis, Jan Elliott and Y. Fujikawa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

J Quinn

95 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Quinn Australia 47 3.6k 2.5k 1.2k 1.0k 937 97 6.1k
Françoise Rédiní France 48 4.1k 1.2× 3.0k 1.2× 1.5k 1.3× 674 0.6× 960 1.0× 181 7.9k
Willy Hofstetter Switzerland 35 2.5k 0.7× 1.5k 0.6× 931 0.8× 1.2k 1.1× 772 0.8× 104 5.3k
Keiichi Ohya Japan 39 2.8k 0.8× 1.5k 0.6× 834 0.7× 608 0.6× 664 0.7× 162 5.5k
Robert A. Dodds United States 37 3.5k 1.0× 1.7k 0.7× 1.2k 1.0× 554 0.5× 613 0.7× 55 5.3k
Jennifer J. Westendorf United States 49 4.9k 1.4× 1.6k 0.6× 916 0.8× 626 0.6× 577 0.6× 141 7.5k
Mitsuo Yamauchi United States 52 3.9k 1.1× 2.3k 0.9× 1.3k 1.0× 1.0k 1.0× 753 0.8× 145 10.7k
Masaaki Goto Japan 34 6.1k 1.7× 4.3k 1.7× 1.2k 1.0× 1.0k 1.0× 764 0.8× 138 9.3k
Kazuhisa Nakashima Japan 30 4.6k 1.3× 1.5k 0.6× 1.6k 1.3× 572 0.5× 296 0.3× 77 6.9k
Yousef Abu‐Amer United States 43 4.2k 1.2× 1.8k 0.7× 1.2k 1.0× 1.4k 1.3× 1.2k 1.3× 113 6.7k
Eero Vuorio Finland 53 3.4k 1.0× 1.1k 0.4× 2.6k 2.1× 1.1k 1.1× 485 0.5× 183 8.3k

Countries citing papers authored by J Quinn

Since Specialization
Citations

This map shows the geographic impact of J Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Quinn more than expected).

Fields of papers citing papers by J Quinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Quinn. The network helps show where J Quinn may publish in the future.

Co-authorship network of co-authors of J Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of J Quinn. A scholar is included among the top collaborators of J Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Quinn. J Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kartsogiannis, Vicky, Natalie A. Sims, J Quinn, et al.. (2008). Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo. Journal of Biological Chemistry. 283(45). 30850–30860. 27 indexed citations
2.
Quinn, J, Natalie A. Sims, Keith Thompson, et al.. (2008). IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice. The Journal of Immunology. 181(8). 5720–5729. 77 indexed citations
3.
Tucker, Elena J., Kristy O’Donnell, Martina Fuchsberger, et al.. (2007). A Novel Mutation in the Nfkb2 Gene Generates an NF-κB2 “Super Repressor”. The Journal of Immunology. 179(11). 7514–7522. 63 indexed citations
4.
Nakamura, Akira, Chi Ly, Natalie A. Sims, et al.. (2007). Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Bone. 40(2). 305–315. 29 indexed citations
5.
Price, John T., J Quinn, Natalie A. Sims, et al.. (2005). The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation. Cancer Treatment Reviews. 31. 1 indexed citations
6.
Sims, Natalie A., Brendan J. Jenkins, J Quinn, et al.. (2004). Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. Journal of Clinical Investigation. 113(3). 379–389. 151 indexed citations
7.
Frew, Ian J., Natalie A. Sims, J Quinn, et al.. (2004). Osteopenia in Siah1a Mutant Mice. Journal of Biological Chemistry. 279(28). 29583–29588. 9 indexed citations
8.
Johnson, Sandra, et al.. (2003). A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis. Biochemical and Biophysical Research Communications. 307(4). 1051–1058. 15 indexed citations
9.
Zhou, Hong, Vicky Kartsogiannis, J Quinn, et al.. (2002). Osteoclast Inhibitory Lectin, a Family of New Osteoclast Inhibitors. Journal of Biological Chemistry. 277(50). 48808–48815. 42 indexed citations
10.
Zhou, Hong, Vicky Kartsogiannis, Jan Elliott, et al.. (2001). A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation. Journal of Biological Chemistry. 276(18). 14916–14923. 62 indexed citations
11.
Itoh, Kanami, Nobuyuki Udagawa, Takenobu Katagiri, et al.. (2001). Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand. Endocrinology. 142(8). 3656–3662. 211 indexed citations
12.
Sabokbar, A, R. Pandey, J Quinn, & N A Athanasou. (1998). Osteoclastic differentiation by mononuclear phagocytes containing biomaterial particles. Archives of Orthopaedic and Trauma Surgery. 117(3). 136–140. 62 indexed citations
13.
Quinn, J, S D Neale, Y. Fujikawa, & J O McGee. (1998). Human Osteoclast Formation from Blood Monocytes, Peritoneal Macrophages, and Bone Marrow Cells. Calcified Tissue International. 62(6). 527–531. 111 indexed citations
14.
Quinn, J, A Sabokbar, & Nick Athanasou. (1996). CELLS OF THE MONONUCLEAR PHAGOCYTE SERIES DIFFERENTIATE INTO OSTEOCLASTIC LACUNAR BONE RESORBING CELLS. The Journal of Pathology. 179(1). 106–111. 51 indexed citations
15.
Joyner, C. J., J Quinn, J T Triffitt, Maureen Owen, & N. A. Athanasou. (1992). Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone and Mineral. 16(1). 37–48. 55 indexed citations
16.
Quinn, J, N A Athanasou, & J O McGee. (1991). Extracellular matrix receptor and platelet antigens on osteoclasts and foreign body giant cells. Histochemistry and Cell Biology. 96(2). 169–176. 20 indexed citations
17.
Athanasou, NA, et al.. (1991). Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. British Journal of Cancer. 63(4). 527–533. 34 indexed citations
19.
Quinn, J, A Heryet, Nick Athanasou, C. G. Woods, & Joanne McGee. (1987). INFLUENCE OF DECALCIFICATION ON THE IMMUNOREACTIVITY OF TISSUE ANTIGENS. The Journal of Pathology and Bacteriology. 151. 1 indexed citations
20.
Athanasou, N A, J Quinn, & J O McGee. (1987). Leucocyte common antigen is present on osteoclasts. The Journal of Pathology. 153(2). 121–126. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026